Loading organizations...
Key people at Subtraction Capital.
Subtraction Capital operates as a venture capital firm specializing in investments within the early-stage enterprise software sector. The firm primarily provides capital alongside comprehensive strategic guidance, operational support, and access to an extensive network, aiming to accelerate the growth and development of its portfolio companies. Its investment approach emphasizes active partnership, working closely with founders to navigate challenges and leverage opportunities in the competitive enterprise technology landscape.
The firm was co-founded in 2013 by Paul Willard and Jason Portnoy. Paul Willard brought extensive experience from his roles as a chief marketing officer at notable tech companies like Atlassian and Practice Fusion, having a background deeply rooted in product development and design. This foundation in operational and strategic roles within technology companies informed the firm's hands-on philosophy from its inception, recognizing the critical support early-stage ventures require beyond mere funding.
Subtraction Capital focuses on supporting founders of nascent enterprise software companies, partnering with those developing solutions for business efficiency and transformation. The firm's long-term vision centers on cultivating robust, enduring businesses that address fundamental needs within the enterprise ecosystem. They seek to invest in companies whose missions and teams align with their own operational values, fostering synergistic relationships designed for sustainable expansion and market impact.
Key people at Subtraction Capital.
# Subtraction Capital: Early-Stage Enterprise Software Investor
Subtraction Capital is a venture capital firm founded in 2013 that specializes in seed and Series A stage investments, with a particular focus on early-stage enterprise software companies[1][2]. The firm operates from dual hubs in the San Francisco Bay Area and Salt Lake City, positioning itself to capture innovation across both major tech ecosystems[2][3]. The firm's investment philosophy centers on leveraging deep operating experience and professional networks to support founders building transformative software solutions for enterprise markets[2].
Beyond pure software, Subtraction Capital has expanded its investment thesis to encompass adjacent sectors including health diagnostics, wearables, medical technology, and personal health solutions[1]. This diversification reflects the firm's recognition that enterprise software increasingly intersects with healthcare and wellness verticals. By maintaining focus on early-stage companies—particularly at the seed and Series A stages—Subtraction Capital positions itself as a foundational investor willing to back founders when conviction is highest but capital is most scarce.
Subtraction Capital was established in 2013, emerging during a period of significant venture capital consolidation and specialization[1]. The firm was founded by managing partner Jason Portnoy, who brought substantial operational credibility from his tenure as Vice President of Financial Planning and Analysis at PayPal[4]. This background is particularly significant: Portnoy's experience at one of the most consequential fintech companies provided him with intimate knowledge of how enterprise software scales, how financial operations function at scale, and what separates successful software companies from those that struggle with unit economics.
The founding of Subtraction Capital during 2013 positioned the firm to capitalize on the emerging wave of cloud-native enterprise software companies. This was the era when companies like Slack, Zendesk, and others were proving that the traditional enterprise software model—characterized by massive upfront licensing fees and lengthy sales cycles—could be disrupted by more efficient, user-centric alternatives. Portnoy's background in financial planning and analysis made him uniquely suited to identify which early-stage software companies possessed the operational discipline and financial rigor to achieve sustainable growth.
Unlike many venture firms that rely primarily on pattern recognition and market analysis, Subtraction Capital explicitly leverages operating experience and deep professional networks[2]. This translates into meaningful support beyond capital deployment—the firm can provide guidance on unit economics, financial modeling, and operational scaling based on real-world experience at a company that achieved massive scale.
The firm's presence in both the San Francisco Bay Area and Salt Lake City reflects a deliberate strategy to access talent and founders across distinct geographic markets[1][2]. While San Francisco remains the epicenter of venture capital, Salt Lake City and the broader US Rockies region have emerged as secondary hubs for enterprise software development, offering lower costs and access to a growing pool of technical talent. This dual positioning allows Subtraction Capital to source deal flow that competitors focused solely on Silicon Valley might miss.
While the firm maintains clear focus on enterprise software, its investment thesis has evolved to encompass health diagnostics, wearables, and medical technology[1]. This represents disciplined expansion rather than unfocused diversification—these sectors share common characteristics with enterprise software, including the need for strong unit economics, scalable distribution, and technical depth.
By concentrating on seed and Series A investments, Subtraction Capital has developed specialized expertise in the most challenging phase of company building—when founders must validate product-market fit with minimal resources and maximum uncertainty[1][2]. This focus allows the firm to develop deep pattern recognition around which teams and ideas are likely to succeed at this critical juncture.
Subtraction Capital operates at a crucial inflection point in venture capital: the democratization of early-stage funding. The firm's 2013 founding coincided with the rise of accelerators, angel syndicates, and smaller seed funds that challenged the traditional model where only established venture firms could access the best early-stage opportunities. By specializing in seed and Series A, Subtraction Capital positioned itself as a bridge between these emerging funding sources and the larger Series B/C investors.
The firm's emphasis on enterprise software reflects a broader market recognition that software-as-a-service (SaaS) and cloud-native applications represent the future of business technology. Unlike consumer software, which is subject to winner-take-most dynamics and network effects, enterprise software allows for multiple successful competitors serving different verticals and use cases. This creates a larger addressable market for venture investors willing to back specialized solutions.
The expansion into health diagnostics and wearables signals Subtraction Capital's recognition that enterprise software increasingly intersects with healthcare—a sector undergoing digital transformation. Companies building software for healthcare providers, diagnostic labs, and wellness platforms require the same operational rigor and financial discipline as traditional enterprise software companies, making them natural extensions of the firm's investment thesis.
Subtraction Capital represents a specific archetype of venture capital firm: the operationally-grounded, geographically-diversified specialist that succeeds by going deep rather than broad. In an era of mega-funds and generalist investors, the firm's focused approach and emphasis on operating experience provide a meaningful differentiation.
Looking forward, Subtraction Capital's influence will likely grow as enterprise software continues to fragment into increasingly specialized verticals. The convergence of software with healthcare, manufacturing, and other traditionally non-tech sectors creates abundant opportunity for investors with both technical credibility and operational experience. The firm's dual geographic presence positions it well to capture innovation emerging from secondary tech hubs, a trend likely to accelerate as remote work and distributed teams become the norm.
The key question for Subtraction Capital's evolution is whether the firm will maintain its disciplined focus on seed and Series A, or whether it will follow the path of many successful early-stage investors by expanding into larger check sizes and later stages. Given the firm's founding thesis and operational model, maintaining specialization in early-stage investing—where operating experience and networks provide the greatest advantage—appears to be the most defensible long-term strategy.
Subtraction Capital has more than 26 tracked investments across 22 companies. The latest tracked deal is $1.0M Seed in Glidance in December 2023.